Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial

Fig. 1

Association between ETS and prognostic outcomes in 128 mCRC patients treated with cetuximab plus chemotherapy. A) Waterfall plots of individual patient tumor shrinkage at 8 weeks from the initiation of treatment. B) Kaplan–Meier curves of PFS according to ETS status. C) Kaplan–Meier curves of OS according to ETS status

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us